[144] RESMED INC SEC Filing

Rhea-AI Filing Summary

ResMed (RMD): Form 144 filed for a planned sale of up to 2,000 common shares. The notice lists an aggregate market value of $504,100, with sales expected on or about 11/12/2025 on the NYSE through Merrill Lynch (2049 Century Park East, Ste 1200, Los Angeles, CA 90067). This is a resale by a security holder under Rule 144; proceeds would go to the seller, not the company.

The filing shows the issuer had 44,448,959 shares outstanding. The shares to be sold were acquired on 09/01/2014 via a stock option for cash, in the amount of 2,000 shares, from Peter C Farrell.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 2049 Century Park East, Ste 1200 Los Angeles CA 90067	2000	504100	44448959	11/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2014	Stock Option	Peter C Farrell			2000	09/01/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did ResMed (RMD) disclose in this Form 144?

A security holder filed a notice to sell up to 2,000 common shares on the NYSE.

What is the aggregate market value of the planned sale for RMD?

The notice lists an aggregate market value of $504,100 for the 2,000 shares.

When might the shares be sold according to the Form 144 for RMD?

The approximate date of sale is 11/12/2025.

Which broker is listed for the Form 144 sale for RMD?

The filing lists Merrill Lynch, 2049 Century Park East, Ste 1200, Los Angeles, CA 90067.

How were the shares intended for sale originally acquired?

They were acquired on 09/01/2014 via a stock option for cash, amount 2,000 shares, from Peter C Farrell.

Will ResMed receive any proceeds from this Form 144 sale?

No. As a Rule 144 resale, proceeds would go to the selling security holder, not to ResMed.

How many ResMed shares were outstanding per the notice?

The filing lists 44,448,959 shares outstanding.